1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow SCD: new trials by email Literature Review of SCD trials Research Report on SCD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Dose Omega 3 in People at Risk for Dementia Omega-3 capsules, Olive oil - Dementia, Inflammation | Phase 2 | Unknown | University Hospital, Akershus | 40 | 2018-10-01 | 2019-04-24 |
| A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) KPS-0373, Placebo - SCD | Phase 2 | Completed | Kissei Pharmaceutical Co., Ltd. | 200 | 2012-12-03 |
Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Dementia (1) · Inflammation (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Pathologic Processes (1) · Spinocerebellar Degenerations (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebellar Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Spinal Cord Diseases (1)
Docosahexaenoic Acids (1) · Olive Oil (1)
Kissei Pharmaceutical Co., Ltd. (1) · University Hospital, Akershus (1)
Japan (1) · Norway (1)
Katsumi Hontani (1) · Tormod Fladby, MD PhD (1)